Related Experiment Video
Updated: Apr 16, 2026

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
Development and validation of the Proxy-Reported Pulmonary Outcomes Scale for premature infants
Wayne A Price1, Sofia R Aliaga1, Sara E Massie2
1Department of Pediatrics, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Insights
The Proxy-Reported Pulmonary Outcome Scale (PRPOS) is a feasible bedside tool for nurses to assess bronchopulmonary dysplasia (BPD) severity in preterm infants using functional measures. It shows internal consistency and validity in initial testing.
Area of Science:
- Neonatology
- Pediatric Pulmonology
- Clinical Assessment Tools
Background:
- Bronchopulmonary dysplasia (BPD) is a significant complication in preterm infants.
- Accurate assessment of BPD severity is crucial for appropriate management and outcomes.
- Existing assessment tools may not fully capture functional respiratory status from a bedside perspective.
Purpose of the Study:
- To evaluate the feasibility of the Proxy-Reported Pulmonary Outcome Scale (PRPOS) as a bedside nurse-reported tool.
- To assess the PRPOS's ability to measure the severity of bronchopulmonary dysplasia (BPD) using functional, disease-related indicators.
- To identify the most reliable items for a final PRPOS measurement tool.
Main Methods:
- A 26-item instrument, the PRPOS, was tested by bedside nurses on preterm infants (born 23-30 weeks gestation).
- Assessments were conducted at 36 to 37(4/7) weeks postmenstrual age, before, during, and after care times.
- Item reliability, validity, and model fit were analyzed to select six final items.
Main Results:
- Assessments were completed on 188 preterm infants.
- PRPOS item scores increased with higher National Institute of Child Health and Development (NICHD) BPD categories.
- The final six-item scale demonstrated internal consistency and known-groups validity.
- PRPOS scores correlated with postmenstrual age at discharge and were higher in infants discharged on oxygen or diuretics.
Conclusions:
- The PRPOS is an internally consistent, proxy-reported measure of respiratory function in premature infants.
- It utilizes observable, functional performance measures for assessing BPD.
- Initial testing supports its known-groups validity, with ongoing research to assess predictive validity.
Objective:
Test the feasibility of using a bedside nurse-reported tool (Proxy-Reported Pulmonary Outcome Scale, PRPOS) for evaluating the severity of bronchopulmonary dysplasia (BPD) by assessing functional, disease-related measures.
Study Design:
Bedside nurses tested the 26-item instrument by observing preterm infants (23-30 weeks at birth) at 36 to 37(4/7) weeks postmenstrual age before, during, and after a care time. We analyzed item reliability, validity, and model fit to determine the six items to include in the final measurement tool.
Result:
We completed assessments on 188 preterm infants. The frequency of an abnormal PRPOS item score increased with increasing National Institute of Child Health and Development (NICHD) BPD category. The six-candidate items produced an internally consistent scale. Addition of the NICHD BPD classification increased reliability moderately; addition of feeding items decreased reliability. The PRPOS score correlated with postmenstrual age at discharge. Infants discharged on oxygen or diuretics had higher median PRPOS scores than did infants who were not prescribed those therapies.
Conclusion:
The PRPOS is an internally consistent, proxy-reported measure of respiratory function in premature infants, based on observable, functional performance measures. Initial testing demonstrates known-groups validity and ongoing testing can assess predictive validity.
More Related Videos
Related Concept Videos
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

